Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia

• Yu-Hung Wang,
• Chien-Chin Lin,
• Kristian Gurashi,
• Chi-Yuan Yao,
• Andres Jerez,
• Hsin-An Hou,
• Wen-Chien Chou,
• Hwei-Fang Tien,
• Kiran Batta,
• Daniel H. Wiseman

Affiliations

Yu-Hung Wang

Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester

Chien-Chin Lin

Division of Hematology, National Taiwan University Hospital

Kristian Gurashi

Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester

Chi-Yuan Yao

Division of Hematology, National Taiwan University Hospital

Andres Jerez

Haematology Department, Hospital Morales Meseguer

Hsin-An Hou

Division of Hematology, National Taiwan University Hospital

Wen-Chien Chou

Division of Hematology, National Taiwan University Hospital

Hwei-Fang Tien

Division of Hematology, National Taiwan University Hospital

Kiran Batta

Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester

Daniel H. Wiseman

Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester